Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,609.58
(
1.58%
)
US TECH 100
23,579.20
(
1.27%
)
Dow Jones
46,426.85
(
1.86%
)
Brent Oil
96.58
(
-10.68%
)
Bitcoin
70,976.55
(
4.63%
)
News Focus
News Focus

Replies to post #125694 on Biotech Values

Replies to #125694 on Biotech Values
icon url

DewDiligence

08/30/11 6:06 AM

#125883 RE: bladerunner1717 #125694

Medivir executive appointments:

http://finance.yahoo.com/news/Medivir-Strengthens-Its-bw-2106672126.html?x=0&.v=1
icon url

DewDiligence

08/31/11 9:17 AM

#125971 RE: bladerunner1717 #125694

Medivir completes patient enrollment in QUEST-1, QUEST-2, and PROMISE phase-3 trials for TMC435:

http://finance.yahoo.com/news/Medivir-Completed-Enrollment-bw-530378270.html?x=0&.v=1

Each trial has 375 patients and uses a response-guided duration of treatment.